glp-1 for bulimia Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review The rapid rise of GLP-1
Description
[1] [2] Additionally, when used with insulin or sulfonylureas, hypoglycemia may occur, potentially causing adrenergic symptoms including palpitations or chest discomfort
The current surge in demand began in 2017, when Novo Nordisk released Ozempic to the market
Referncias: Giblin K, Kaplan LM, Somers VK, Le Roux CW, Hunter DJ, Wu Q, Lalonde A, Ahmad N, Bethel MA
Once you start taking Ozempic, call in your refill a few days before you need it in case the pharmacy has to order it or any other delay, to avoid an interruption in your treatment
